For Indian vaccine makers, a lot hinges on the WTO

The Morning Context

T Surendar

Mumbai

10 December 2020

UNLOCK NOW!

The opportunity beckons. For the global pharmaceutical industry, it’s a race against the clock to vaccinate the world’s population against COVID-19. And, who better than India to supply the shots, in the cheapest and quickest way possible.

The only Indian company that has made headlines so far is the Pune-based Serum Institute of India, which also happens to be the world’s largest manufacturer of vaccines. The company tied up with AstraZeneca, to bring a vaccine developed by the British-Swedish multinational firm along with UK’s Oxford University to the Indian market. SII will produce a billion doses of the vaccine by 2021-22, including 400 million this year, and is ready to push its stock into the market as soon as the vaccine is approved by the government.

The other companies in the race have largely been silent so far. Two among them came into the limelight after Prime Minister Narendra Modi’s whistle-stop tour to take stock of vaccine production

What our readers say

Why subscribers love The Morning Context

High quality, independent journalism is rare to find. The Morning Context set really high standards that make me wait for each story.

Abhay Pandey, Managing partner, A91 Capital

Well-written and researched long form reads on a wide variety of topics and a team of veteran journalists - all of this makes my subscription worth it.

Anupam Gupta, Investment research consultant

In today's very noisy and cluttered world, I like that the Morning Context goes below the surface of company PR to deliver fact-based stories on Indian business.

Jessie Paul, CEO, Paul Writer

The Morning Context is my daily opportunity to get smarter about one new company/sector. Discerning analysis, unbiased and approachable.

Miten Sampat, Angel investor & former CSO, Times Internet

In today's polarized world, authentic and unbiased facts are in short supply world over. The Morning Context is a refreshing approach towards truthful, well researched, fearless, and high-quality articles on contemporary topics.

N S Parthasarthy, Co-founder, Mindtree

As one of the early subscribers, I've had the opportunity to witness how quickly the team has grown, the variety of angles covered, and the research in every in-depth story and op-ed.

Amarjit Batra, Managing director, Spotify India

In a world full of noise, The Morning Context is the calm that stimulates and energises your mind, with stories focused on fact, truth and dogged reportage.

Nikhil Taneja, Co-founder and CEO, Yuvaa

Although it’s a paid subscription, the kind of detailed research and quality of reportage makes it worth every rupee. It’s strength surely lies in having some of the finest journalists writing for it.

Shiladitya Bora, Producer, distributor and founder at Platoon One Films

Become a TMC member